← Leaderboards
David Aaron Jacobson
Northwestern University At Chicago
$9,926,056
Attributed
$10,201,296
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,201,296 · 11
By mechanism
R01$9,459,116 · 6
K01$504,685 · 1
R03$231,270 · 2
M01$6,225 · 2
Top collaborators
- Seung K Kim1 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Laura Andrea Dada$693,114
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIsletInsulin SecretionGlucoseDiabetes MellitusCell PhysiologyNew Therapeutic TargetPhysiologicalNon-Insulin-Dependent Diabetes MellitusIslets Of LangerhansInsulinInsightBlood Glucose RegulationPotassium ChannelAnimal Disease ModelsIon ChannelIslet CellTransgenic MiceCoupledStressAblationResponseFunctional DisorderMembrane Potentials
Grant awards (36)
Calcium Extrusion in the Context of Pancreatic Islet Function and Dysfunction$631,259
R01 · FY2025 · DK · contact PI
Investigating mechanisms underlying diabetes associated with exocrine pancreas diseases$550,481
R01 · FY2025 · DK
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetes$505,744
R01 · FY2025 · DK · contact PI
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction$449,622
R01 · FY2025 · DK · contact PI
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetes$485,515
R01 · FY2024 · DK · contact PI
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction$431,638
R01 · FY2024 · DK · contact PI
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction$72,900
R01 · FY2024 · DK · contact PI
Secretagogue and Gi/o-GPCR signaling through the islet Na+/K+-ATPase in health and diabetes$505,744
R01 · FY2023 · DK · contact PI
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction$449,622
R01 · FY2023 · DK · contact PI
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction$30,368
R01 · FY2023 · DK · contact PI
Molecular Mechanisms Regulating Pancreatic Delta Cell Function and Dysfunction$449,622
R01 · FY2022 · DK · contact PI
Two-Pore-Domain Potassium Channels as Novel Targets for Modulating Islet Hormone Secretion$395,841
R01 · FY2022 · DK · contact PI
Designing selective TALK-1 inhibitors to reduce beta-cell dysfunction in diabetes$392,391
R01 · FY2021 · DK · contact PI
Two-Pore-Domain Potassium Channels as Novel Targets for Modulating Islet Hormone Secretion$392,108
R01 · FY2021 · DK · contact PI
Designing selective TALK-1 inhibitors to reduce beta-cell dysfunction in diabetes$392,393
R01 · FY2020 · DK · contact PI
Two-Pore-Domain Potassium Channels as Novel Targets for Modulating Islet Hormone Secretion$392,116
R01 · FY2020 · DK · contact PI
Designing selective TALK-1 inhibitors to reduce beta-cell dysfunction in diabetes$392,395
R01 · FY2019 · DK · contact PI
Two-Pore-Domain Potassium Channels as Novel Targets for Modulating Islet Hormone Secretion$392,124
R01 · FY2019 · DK · contact PI
Designing selective TALK-1 inhibitors to reduce beta-cell dysfunction in diabetes$392,397
R01 · FY2018 · DK · contact PI
2-pore-domain K+ channels as novel targets for modulating islet hormone secretion$341,475
R01 · FY2017 · DK · contact PI
2-pore-domain K+ channels as novel targets for modulating islet hormone secretion$357,960
R01 · FY2016 · DK · contact PI
2-pore-domain K+ channels as novel targets for modulating islet hormone secretion$357,960
R01 · FY2015 · DK · contact PI
2-Pore-Domain K+ Channels as Novel Targets for Modulating Islet Hormone Secretion$16,485
R01 · FY2015 · DK · contact PI
2-pore-domain K+ channels as novel targets for modulating islet hormone secretion$341,475
R01 · FY2014 · DK · contact PI
2-pore-domain K+ channels as novel targets for modulating islet hormone secretion$339,481
R01 · FY2013 · DK · contact PI
Pancreatic beta-cell CAMKII signaling under physiological and diabetic conditions$75,270
R03 · FY2013 · DK · contact PI
Small molecule modulators of the two-pore-domain potassium channel, TREK-2$39,000
R03 · FY2013 · MH · contact PI
Secretagogue Induced Mechanisms Regulating Islet Electrical Activity$145,001
K01 · FY2012 · DK · contact PI
Pancreatic beta-cell CAMKII signaling under physiological and diabetic conditions$78,000
R03 · FY2012 · DK · contact PI
Small molecule modulators of the two-pore-domain potassium channel, TREK-2$39,000
R03 · FY2012 · MH · contact PI
Secretagogue Induced Mechanisms Regulating Islet Electrical Activity$145,001
K01 · FY2011 · DK · contact PI
Secretagogue Induced Mechanisms Regulating Islet Electrical Activity$102,339
K01 · FY2010 · DK · contact PI
Secretagogue Induced Mechanisms Regulating Islet Electrical Activity$6,190
K01 · FY2010 · DK · contact PI
Secretagogue induced mechanisms regulating islet electrical activity$106,154
K01 · FY2009 · DK · contact PI
PEDIATRIC GVHD - PHARMACOKINETICS & BIOAVAILABILITY OF IV METHYLPREDNISOLONE$4,113
M01 · FY2007 · RR · contact PI
PEDIATRIC GVHD - PHARMACOKINETICS & BIOAVAILABILITY OF IV METHYLPREDNISOLONE$2,112
M01 · FY2006 · RR · contact PI